Lena Söderström is taking over the role as Biomedical Bonding’s (BMB) representative on the BoneFix Exploitation Board and Steering Committee.
Lena has over 30 years’ experience in management positions in international pharmaceutical and medical device companies, and is currently on the board of several life science companies, innovation holding companies as well as the Stockholm Chamber of Commerce.
Lena joined BMB in 2021 and is excited to be a part of the development of this new implant technology. Being a productive and engaged leader with vast experience in the field, BMB saw it as a logical step to offer Lena to be part of BoneFix. She will help the project to grow and reach out to the medical device and general community. Lena will also assist the consortium by developing its communication and exploitation strategies as well as by creating contacts with key stakeholders.
Lena says: “It is a great opportunity for me to learn new things and get valuable insights from this multidisciplinary project with leading researchers from so many fields. I believe the technology that BMB and BoneFix are developing is the future of fracture treatment and I am so excited to be part of the journey”.
Lena will take part in BMB’s activities in WP9 and guide the project in areas of her expertise